Jove
Visualize
Contact Us

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

111
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
111

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The genome sequence of the solitary wasp, <i>Nysson trimaculatus</i> (Rossi, 1790) (Hymenoptera: Crabronidae).

Wellcome open research·2026
Same author

ColonCrafter: A Depth Estimation Model for Colonoscopy Videos Using Diffusion Priors.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same author

The genome sequence of the Square-spot Deerfly, <i>Chrysops viduatus</i> (Fabricius, 1794) (Diptera: Tabanidae).

Wellcome open research·2026
Same author

The genome sequence of the Dune Robberfly, <i>Philonicus albiceps</i> (Meigen, 1820).

Wellcome open research·2026
Same author

The genome sequence of a tephritid fruit fly, <i>Xyphosia miliaria</i> (Schrank, 1781) (Diptera: Tephritidae).

Wellcome open research·2026
Same author

The Endo-GeneScreen platform identifies drug-like probes that regulate endogenous protein levels within physiological contexts.

Nature communications·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 9, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

924

Improving nonalcoholic fatty liver disease classification performance with latent diffusion models.

Romain Hardy1, Joe Klepich1, Ryan Mitchell1

  • 1School of Information, U.C. Berkeley, Berkeley, CA, USA.

Scientific Reports
|December 7, 2023
PubMed
Summary

Synthetic images from diffusion models improve nonalcoholic fatty liver disease (NAFLD) classification, even with limited real data. This approach enhances diagnostic tools for medical professionals.

More Related Videos

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
05:37

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Published on: October 20, 2023

1.4K
The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
09:27

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

Published on: June 17, 2016

12.1K

Related Experiment Videos

Last Updated: Jul 9, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

924
Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
05:37

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Published on: October 20, 2023

1.4K
The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
09:27

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

Published on: June 17, 2016

12.1K

Area of Science:

  • Medical Imaging
  • Artificial Intelligence in Healthcare
  • Machine Learning for Diagnostics

Background:

  • Deep learning offers potential for improved medical diagnostics but requires extensive annotated data.
  • The scarcity of annotated medical images hinders the application of machine learning models in healthcare.
  • Nonalcoholic fatty liver disease (NAFLD) diagnosis can benefit from advanced computational methods.

Purpose of the Study:

  • To investigate the efficacy of using synthetic images generated by diffusion models to augment real medical images for NAFLD classification.
  • To compare the quality of synthetic images produced by diffusion models versus Generative Adversarial Networks (GANs).
  • To assess the performance enhancement in NAFLD prediction using synthetic data augmentation in low-data scenarios.

Main Methods:

  • Generated synthetic medical images using diffusion models and compared them with GAN-generated images.
  • Evaluated synthetic image quality using Inception Score (IS) and Fréchet Inception Distance (FID).
  • Employed a partially frozen Convolutional Neural Network (CNN) backbone (EfficientNet v1) for NAFLD classification with synthetic data augmentation.

Main Results:

  • Diffusion-generated images demonstrated superior quality, achieving a higher maximum IS (1.90 vs. 1.67) and a lower minimum FID (69.45 vs. 100.05) compared to GANs.
  • The synthetic augmentation method, combined with a CNN, achieved a maximum ROC AUC of 0.904 for image-level NAFLD prediction.
  • Performance enhancement was observed even in low-data regime settings, highlighting the method's effectiveness.

Conclusions:

  • Diffusion models are effective in generating high-quality synthetic medical images suitable for data augmentation.
  • Synthetic image augmentation using diffusion models significantly improves NAFLD classification performance, particularly in data-scarce environments.
  • This research provides a viable strategy to overcome data limitations in medical AI, enhancing diagnostic capabilities.